Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer.
Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer. Cancer Epidemiol Biomarkers Prev. 2016 05; 25(5):807-14.